Shanghai Kinetic Medical Co
Shanghai Kinetic Medical Co., Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of medical devices in China and internationally. The company offers invasive spinal, invasive vertebroplasty, radiofrequency ablation, orthopedic trauma implant equipment, artificial organs, orthopedic surgical instruments, and other medical products, as well as surgica… Read more
Shanghai Kinetic Medical Co (300326) - Net Assets
Latest net assets as of September 2025: CN¥2.88 Billion CNY
Based on the latest financial reports, Shanghai Kinetic Medical Co (300326) has net assets worth CN¥2.88 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.38 Billion) and total liabilities (CN¥495.68 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.88 Billion |
| % of Total Assets | 85.33% |
| Annual Growth Rate | 38.0% |
| 5-Year Change | 4.9% |
| 10-Year Change | 114.11% |
| Growth Volatility | 92.92 |
Shanghai Kinetic Medical Co - Net Assets Trend (2008–2024)
This chart illustrates how Shanghai Kinetic Medical Co's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shanghai Kinetic Medical Co (2008–2024)
The table below shows the annual net assets of Shanghai Kinetic Medical Co from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.82 Billion | -4.40% |
| 2023-12-31 | CN¥2.95 Billion | +4.76% |
| 2022-12-31 | CN¥2.81 Billion | +1.31% |
| 2021-12-31 | CN¥2.78 Billion | +3.39% |
| 2020-12-31 | CN¥2.69 Billion | -2.35% |
| 2019-12-31 | CN¥2.75 Billion | +9.99% |
| 2018-12-31 | CN¥2.50 Billion | +22.55% |
| 2017-12-31 | CN¥2.04 Billion | +10.88% |
| 2016-12-31 | CN¥1.84 Billion | +39.86% |
| 2015-12-31 | CN¥1.32 Billion | +20.23% |
| 2014-12-31 | CN¥1.10 Billion | +115.15% |
| 2013-12-31 | CN¥508.97 Million | +14.40% |
| 2012-12-31 | CN¥444.92 Million | +373.67% |
| 2011-12-31 | CN¥93.93 Million | +22.30% |
| 2010-12-31 | CN¥76.80 Million | +96.43% |
| 2009-12-31 | CN¥39.10 Million | +139.91% |
| 2008-12-31 | CN¥16.30 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Kinetic Medical Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 8367.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.13 Billion | 41.63% |
| Common Stock | CN¥717.03 Million | 26.35% |
| Other Comprehensive Income | CN¥177.50 Million | 6.52% |
| Other Components | CN¥693.59 Million | 25.49% |
| Total Equity | CN¥2.72 Billion | 100.00% |
Shanghai Kinetic Medical Co Competitors by Market Cap
The table below lists competitors of Shanghai Kinetic Medical Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Chung Hung Steel Corp
TW:2014
|
$458.80 Million |
|
FIT Hon Teng Limited
PINK:FITGF
|
$458.84 Million |
|
Ning Xia Yin Xing Energy Co Ltd
SHE:000862
|
$459.10 Million |
|
Genting Plantations Bhd
KLSE:2291
|
$459.37 Million |
|
BOUVET ASA NK 01
F:BV4
|
$458.49 Million |
|
Fengfan Power
SHG:601700
|
$458.45 Million |
|
NV Nederlandsche Apparatenfabriek Nedap
AS:NEDAP
|
$458.45 Million |
|
Jinlongyu Group Co Ltd Class A
SHE:002882
|
$458.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Kinetic Medical Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,859,842,987 to 2,720,915,236, a change of -138,927,751 (-4.9%).
- Net loss of 105,565,367 reduced equity.
- Dividend payments of 46,136,611 reduced retained earnings.
- Other comprehensive income increased equity by 177,495,831.
- Other factors decreased equity by 164,721,604.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-105.57 Million | -3.88% |
| Dividends Paid | CN¥46.14 Million | -1.7% |
| Other Comprehensive Income | CN¥177.50 Million | +6.52% |
| Other Changes | CN¥-164.72 Million | -6.05% |
| Total Change | CN¥- | -4.86% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Kinetic Medical Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.61x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 137.94x to 1.61x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | CN¥0.04 | CN¥6.10 | x |
| 2009-12-31 | CN¥0.11 | CN¥6.10 | x |
| 2010-12-31 | CN¥0.19 | CN¥6.10 | x |
| 2011-12-31 | CN¥0.23 | CN¥6.10 | x |
| 2012-12-31 | CN¥0.92 | CN¥6.10 | x |
| 2013-12-31 | CN¥0.92 | CN¥6.10 | x |
| 2014-12-31 | CN¥1.81 | CN¥6.10 | x |
| 2015-12-31 | CN¥1.83 | CN¥6.10 | x |
| 2016-12-31 | CN¥2.63 | CN¥6.10 | x |
| 2017-12-31 | CN¥2.82 | CN¥6.10 | x |
| 2018-12-31 | CN¥3.48 | CN¥6.10 | x |
| 2019-12-31 | CN¥3.81 | CN¥6.10 | x |
| 2020-12-31 | CN¥3.76 | CN¥6.10 | x |
| 2021-12-31 | CN¥3.79 | CN¥6.10 | x |
| 2022-12-31 | CN¥3.81 | CN¥6.10 | x |
| 2023-12-31 | CN¥3.99 | CN¥6.10 | x |
| 2024-12-31 | CN¥3.79 | CN¥6.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Kinetic Medical Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.88%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -10.72%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.23x
- Recent ROE (-3.88%) is below the historical average (17.92%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 83.41% | 58.31% | 1.23x | 1.16x | CN¥11.96 Million |
| 2009 | 45.82% | 46.20% | 0.74x | 1.34x | CN¥14.00 Million |
| 2010 | 46.36% | 60.66% | 0.66x | 1.16x | CN¥27.92 Million |
| 2011 | 39.53% | 46.01% | 0.69x | 1.24x | CN¥27.74 Million |
| 2012 | 12.48% | 54.60% | 0.22x | 1.06x | CN¥11.03 Million |
| 2013 | 12.58% | 50.56% | 0.21x | 1.20x | CN¥13.15 Million |
| 2014 | 5.96% | 27.99% | 0.17x | 1.26x | CN¥-42.19 Million |
| 2015 | 10.33% | 26.06% | 0.27x | 1.45x | CN¥3.86 Million |
| 2016 | 8.64% | 28.85% | 0.25x | 1.21x | CN¥-25.04 Million |
| 2017 | 9.62% | 24.30% | 0.30x | 1.33x | CN¥-7.69 Million |
| 2018 | 18.51% | 49.69% | 0.26x | 1.43x | CN¥212.70 Million |
| 2019 | 11.00% | 24.73% | 0.32x | 1.37x | CN¥27.50 Million |
| 2020 | -4.79% | -11.92% | 0.29x | 1.39x | CN¥-390.84 Million |
| 2021 | 5.92% | 12.75% | 0.36x | 1.28x | CN¥-111.58 Million |
| 2022 | -0.78% | -1.83% | 0.34x | 1.25x | CN¥-295.24 Million |
| 2023 | 3.94% | 11.77% | 0.29x | 1.17x | CN¥-173.45 Million |
| 2024 | -3.88% | -10.72% | 0.29x | 1.23x | CN¥-377.66 Million |
Industry Comparison
This section compares Shanghai Kinetic Medical Co's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Kinetic Medical Co (300326) | CN¥2.88 Billion | 83.41% | 0.17x | $458.69 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |